A measles outbreak and hospitals’ financial troubles

Many patients using GLP-1 drugs like Wegovy may not regain lost weight quickly when they stop treatment, an analysis of real-world data shows

Plans for a controversial U.S.-funded hepatitis B vaccine study in Guinea-Bissau have been paused pending further review from national authorities.

A $450 million deal would leave Huntsville, Ala., with a single hospital system, unless regulators step in.

This is the web edition of D.C. Diagnosis, STAT's newsletter about the politics and policy of health and medicine.

And more biotech news from The Readout newsletter

The chair of a federal vaccine advisory panel charted a new course for the committee in a podcast released Thursday, questioning longstanding recommendations.

The number of ongoing prescription drug shortages rose slightly in the last quarter of 2025, but remained significantly lower than the all-time high reached in the beginning of 2024.